High 2 Well being Care Shares You Might Need To Dump This Quarter – Medpace Hldgs (NASDAQ:MEDP), Recursion Prescription drugs (NASDAQ:RXRX)

As of July 22, 2025, two shares within the well being care sector could possibly be flashing an actual warning to buyers who worth momentum as a key standards of their buying and selling selections.

The RSI is a momentum indicator, which compares a inventory’s energy on days when costs go as much as its energy on days when costs go down. When in comparison with a inventory’s worth motion, it may give merchants a greater sense of how a inventory could carry out within the quick time period. An asset is often thought of overbought when the RSI is above 70, in accordance with Benzinga Pro.

This is the most recent checklist of main overbought gamers on this sector.

Medpace Holdings Inc MEDP

• On July 21, Medpace Holdings reported better-than-expected second-quarter monetary outcomes and raised its FY25 steering above estimates. Medpace expects 2025 income to be within the vary of $2.42 billion to $2.52 billion, up from prior steering of $2.14 billion to $2.24 billion. The corporate additionally raised its full-year earnings steering from a spread of $12.26 to $13.04 per share versus estimates of $13.76 to $14.53 per share. Analysts are forecasting 2025 income of $2.18 billion and earnings of $12.69 per share. The corporate’s inventory jumped round 192% over the previous 5 years and has a 52-week excessive of $440.38.
• RSI Worth: 83.2                                
• MEDP Value Motion: Shares of Medpace fell 1% to shut at $308.88 on Monday.
• Edge Inventory Rankings: 19.90 Momentum rating with Worth at 23.62.

Recursion Prescription drugs Inc RXRX

• On July 8, Recursion Prescription drugs introduced it acquired the joint ENPP1 inhibitor program and related backup molecule from Rallybio. “We prolong our honest due to Rallybio for his or her invaluable partnership in advancing this program to its present stage,” mentioned David Hallett, Chief Scientific Officer of Recursion. The corporate’s inventory gained round 33% over the previous month has a 52-week excessive of $12.36.
• RSI Worth: 75.6
• RXRX Value Motion: Shares of Recursion Prescription drugs gained 9.6% to shut at $6.40 on Monday.

Inquisitive about different BZ Edge Rankings? Click on right here to find how comparable shares measure up.

Learn This Subsequent:

Photograph by way of Shutterstock